Latest Travel News

Web Travel Group has reported a robust first half for FY26 with bookings and transaction values significantly up, setting the stage for a record EBITDA year despite slight margin pressures.

Webjet Group has completed its acquisition of Locomote Holdings for $23 million, aiming to fast-track its digital business travel platform and reduce development risks. The move aligns with Webjet’s FY30 Strategic Plan to expand its footprint in corporate travel.

Webjet Group Limited has received a shareholder requisition backed by significant investors seeking to appoint new directors and remove recent board appointees, signaling potential shifts in company governance.

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, reshuffling key constituents across multiple S&P/ASX indices effective September 22. The changes highlight shifting market dynamics with notable additions and removals in sectors ranging from technology to resources.

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, with significant additions and removals across multiple ASX indices set to take effect before market open on September 22.

8common’s subsidiary Expense8 has renewed its contract with the NSW Department of Education for another two years, reinforcing its role as a key provider of travel and expense management software in government.

Corporate Travel Management Limited’s shares remain suspended on the ASX as the company delays lodging its Preliminary Final Report amid ongoing financial restatement concerns.

Vanadium Resources Limited has extended the deadline to finalise pricing terms with China Precious Asia Limited, while progressing mining contractor discussions and pit optimisation at its Steelpoortdrift vanadium project.

8common Limited reported a significant narrowing of its net loss for FY25 alongside a 16% growth in SaaS revenue and improved gross margins, positioning the company for profitability in FY26.

4DMedical Limited reported a 56% jump in FY2025 operating revenue driven by SaaS growth, while narrowing its net loss to $30.1 million. The company also secured $13.9 million in capital and a $10 million funding facility to accelerate product commercialisation.

Immuron Ltd reported a robust 49% increase in FY25 global sales, driven by strong Travelan® growth, while gearing up for a ProIBS launch and pivotal FDA meetings in 2025-26.

FlexiRoam Limited reported an 8.6% revenue decline for FY25 but achieved a remarkable turnaround in the second half, posting positive EBITDA and net profit after a CEO-led operational reset.